RT Journal Article
SR Electronic
T1 699 Phase 2 trial of brentuximab vedotin (BV) with pembrolizumab (pembro) in patients with metastatic non-small cell lung cancer or metastatic cutaneous melanoma after progression on anti-PD-1 therapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A794
OP A794
DO 10.1136/jitc-2023-SITC2023.0699
VO 11
IS Suppl 1
A1 Lee, Sylvia
A1 Jotte, Robert M
A1 Gillespie-Twardy, Amanda
A1 Mehmi, Inderjit
A1 Chandra, Sunandana
A1 Zakharia, Yousef
A1 Hamid, Omid
A1 Watson, Graham
A1 Ward, Patrick
A1 Chaney, Marya
A1 Lu, Hailing
A1 Berndt, Jason D
A1 Rathi, Kapil
A1 Knowles, Scott
A1 O’Connor, Brian P
A1 Cowey, Charles
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A794.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.